- Pharmacokinetics, safety, and tolerability of the novel oral direct Renin inhibitor aliskiren in elderly healthy subjects. Vaidyanathan, S., Reynolds, C., Yeh, C.M., Bizot, M.N., Dieterich, H.A., Howard, D., Dole, W.P. Journal of clinical pharmacology (2007)